VR

Venkataraman Rajagopal Devarajan

Active Director Director DIN 11565746
DIN 11565746 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkataraman Rajagopal Devarajan

Data last updated:

Venkataraman Rajagopal Devarajan is a Director at Bullz India Remedies Private Limited (since 2026). The company operates in Pharma.

DIN 11565746
Primary Designation Director
Industry Pharma
First Appointment 23 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bullz India Remedies Private Limited U46497TZ2026PTC038039
Director23 Feb 20262026Active

Board colleagues of Venkataraman Rajagopal Devarajan

NameDINCompanyDesignation
Krishnan Sobiya11565747Bullz India Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bullz India Remedies Private Limited
Premium access

Shareholding and investment profile for Venkataraman Rajagopal Devarajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkataraman Rajagopal Devarajan

Venkataraman Rajagopal Devarajan currently holds 1 directorship: Bullz India Remedies Private Limited (Director, since 23 Feb 2026).

Venkataraman Rajagopal Devarajan was first appointed on 23 Feb 2026 as Director at Bullz India Remedies Private Limited.

The current boards of Venkataraman Rajagopal Devarajan's companies include Krishnan Sobiya (Bullz India Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available